13F Holdings
中文EN

ARCH Venture Management, LLC

CHICAGO IL · SEC CIK 0001274403

2026Q22026Q1 9 earlier quarters 🔒
$1.10B2026Q2 reported value
12Positions
99.3%Top 10 weight · largest 16.0%
1 / 1New / sold out
Reported value over time$1.10B2026Q2
26Q126Q2

All 11 quarters on paid plans 🔒

Top 10 holdings % of portfolio

PBLS 16.0%
BEAM 14.2%
RAPP 14.1%
SPTX 12.4%
ERAS 11.8%
VIR 11.8%
MAZE 11.2%
LYEL 4.1%
GENB 3.0%
TXG 0.8%

2026Q2 top buys estimated at quarter-end value

BOUNDLESS BIO IN New+$6.74M

2026Q2 top sells estimated at quarter-end value

VIR Reduced-$2.27M
QTTB Sold out-$2.06M

2026Q2 holdings click a header to sort

Export CSV 🔒
TickerNameValue ▼WeightSharesShare changeChangeEst. flowAction
PBLS PARABILIS MEDICINES INC $175.52M15.95%6,412,780 6,412,780— — First reported
BEAM BEAM THERAPEUTICS INC $155.77M14.16%4,540,132 00.0% — Unchanged
RAPP RAPPORT THERAPEUTICS INC $155.38M14.12%3,728,738 00.0% — Unchanged
SPTX SEAPORT THERAPEUTICS INC $136.60M12.42%6,294,951 6,294,951— — First reported
ERAS ERASCA INC $129.92M11.81%7,091,557 00.0% — Unchanged
VIR VIR BIOTECHNOLOGY INC $129.35M11.76%12,694,163 -222,500-1.7% -$2.27M Reduced
MAZE MAZE THERAPEUTICS INC $122.98M11.18%4,120,053 00.0% — Unchanged
LYEL LYELL IMMUNOPHARMA INC $45.53M4.14%3,247,162 00.0% — Unchanged
GENB GENERATE BIOMEDICINES INC $32.80M2.98%1,944,426 00.0% — Unchanged
TXG 10X GENOMICS INC $8.35M0.76%217,834 00.0% — Unchanged
— BOUNDLESS BIO INC $6.74M0.61%2,694,095 2,694,095— $6.74M New
— GOSSAMER BIO INC $1.33M0.12%8,055,916 00.0% — Unchanged
QTTB Q32 BIO INC $00.00%0 -320,482-100.0% -$2.06M Sold out